Jonathan Lanfear
Chief Operating Officer at Hibercell, Inc.
Net worth: - $ as of 30/03/2024
Profile
Jonathan Lanfear is currently the Director at Aquinnah Pharmaceuticals, Inc., the Chief Operating Officer at Hibercell, Inc., and the Principal at Lanfear Advisors LLC.
He previously worked as a Senior Director at Pfizer Inc., the VP & Global Head-Oncology at Takeda Pharmaceuticals International, Inc., an Independent Director at Molecular Templates, Inc., and a Director at ARTham Therapeutics, Inc. Lanfear holds an MBA from the University of Washington and undergraduate and graduate degrees from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/10/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Jonathan Lanfear active positions
| Companies | Position | Start |
|---|---|---|
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Director/Board Member | - |
| Lanfear Advisors LLC | Corporate Officer/Principal | - |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Chief Operating Officer | 29/09/2021 |
Former positions of Jonathan Lanfear
| Companies | Position | End |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Director/Board Member | 10/01/2024 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The private company is based in Deerfield, IL. | Corporate Officer/Principal | 30/09/2020 |
| PFIZER, INC. | Corporate Officer/Principal | 31/12/2010 |
ARTham Therapeutics, Inc.
 ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The private company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Director/Board Member | - |
Training of Jonathan Lanfear
| University of Washington | Masters Business Admin |
| University of Michigan | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The private company is based in Deerfield, IL. | Commercial Services |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |
ARTham Therapeutics, Inc.
ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The private company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Health Technology |
| Lanfear Advisors LLC |
- Stock Market
- Insiders
- Jonathan Lanfear
